Company / Interest Expense
Enovis Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$34.8M
FY2025
5-year range
$29.1M / $57.1M
FY2021-FY2025
Trend
-39.0%
vs FY2024
Sector context
#29 of 44
Health Care
What the data says
At $35M, Enovis's interest expense ranks #16 of 44 in the Health Care sector. Interest Expense has fluctuated over the past 10 years, ranging from $29M in FY2023 to $57M in FY2024.
Based on SEC 10-K filings.
$35M in FY2025 with a 5-year CAGR of -6.6%.
Increased from $29M to $35M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -13.0%
- 5-Year CAGR
- -6.6%
- 10-Year CAGR
- -
Sector benchmark
#16 of 44 in Health CareTop 34% of 44This company $34.8M Sector average $316.9M
▼
-89.0% below sector average
Key checks
Key Insights
- 5-year CAGR of -6.6%, indicating a declining trend.
- In FY2025, interest expense decreased 39.0% year-over-year.
- Ranks #29 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.27 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $34.8M | -39.0% |
| FY2024 | $57.1M | +96.1% |
| FY2023 | $29.1M | -44.9% |
| FY2022 | $52.8M | +81.5% |
| FY2021 | $29.1M | -40.7% |
| FY2020 | $49.1M | +22.4% |
| FY2019 | $40.1M | -18.3% |
| FY2018 | $49.1M | +3.3% |
| FY2017 | $47.5M | +56.9% |
| FY2016 | $30.3M | -70.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026